包容类型对自体骨软骨移植治疗距骨骨软骨损伤临床结局的影响
回顾性队列研究纳入2006至2014年接受自体骨软骨移植的94例距骨骨软骨损伤患者,比较包容型与无包容型损伤的临床和影像结局。包容型患者末次随访FAOS中位数高于无包容型(91.7 vs 85.0,P=0.009),但SF-12和MOCART评分无显著差异;多因素回归显示包容型FAOS评分约高10分(P=0.006)。两组术后FAOS和SF-12均较术前显著改善(P<0.001)。
要点
- 包容型距骨骨软骨损伤自体骨软骨移植后FAOS中位数高于无包容型(91.7 vs 85.0,P=0.009)。
- 多因素回归显示包容型损伤FAOS评分较无包容型约高10分(P=0.006)。
- 两组术后SF-12和MOCART评分无显著差异,且两组FAOS和SF-12均较术前显著改善(P<0.001)。
核心结论
- 包容型距骨骨软骨损伤患者接受自体骨软骨移植后临床结局优于无包容型患者。
- 但中期随访时自体骨软骨移植在包容型和无包容型损伤中均提供了良好的临床和MRI结局。
研究设计与样本
- 病例对照研究,证据等级3级;为回顾性队列研究,比较包容型与无包容型距骨骨软骨损伤患者。
- 纳入2006年至2014年间因距骨骨软骨损伤接受自体骨软骨移植的所有患者,共94例:包容型31例,无包容型63例。
- 包容型组患者年龄中位数34岁(四分位距28-48岁),无包容型组36岁(四分位距27-46岁)。
- 包容型组随访时间中位数45个月(四分位距38-63个月),无包容型组52个月(四分位距40-66个月)。
主要发现
- 包容型和无包容型损伤术后FAOS和SF-12评分中位数均较术前显著改善(P < .001)。
- 包容型患者术后FAOS评分中位数高于无包容型患者(91.7 vs 85.0,P = .009)。
- 包容型与无包容型组术后SF-12和MOCART评分无显著差异。
- 多因素回归模型显示,包容型患者FAOS评分较无包容型患者约高10分(P = .006)。
- 无包容型损伤囊性发生率高于包容型,但差异未达统计学显著(55.6% vs 38.7%,P = .125)。
关键数值与推荐
- 临床结局采用足踝结局评分(FAOS)和12项简短健康调查(SF-12)于术前和末次随访评估。
- 随访2年时磁共振成像采用改良软骨修复组织磁共振观察(MOCART)评分评估。
- 采用多因素回归模型评估影响术后FAOS、SF-12和MOCART评分的因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uncontained-type osteochondral lesions of the talus (OLTs) have been shown to have inferior clinical outcomes after treatment with bone marrow stimulation. While autologous osteochondral transplantation (AOT) is indicated for larger lesions, no study has reported on the prognostic significance of the containment of OLTs treated with the AOT procedure. PURPOSE: To clarify the effect of the containment of OLTs on clinical and radiological outcomes in patients who underwent AOT for OLTs. STUDY DESIGN: Case control study; Level of evidence, 3. METHODS: A retrospective cohort study comparing patients with contained-type and uncontained-type OLTs was undertaken to include all patients who underwent AOT for the treatment of OLTs between 2006 and 2014. Analyses were performed by grouping the patients according to the containment type. Clinical outcomes were evaluated using the Foot and Ankle Outcome Score (FAOS) and the 12-Item Short Form Health Survey (SF-12) preoperatively and at final follow-up. Magnetic resonance imaging (MRI) at 2 years' follow-up was evaluated with the modified magnetic resonance observation of cartilage repair tissue (MOCART) score. Multivariate regression models were used to evaluate factors affecting postoperative FAOS, SF-12, and MOCART scores. RESULTS: Ninety-four patients were included: 31 patients with a contained-type OLT and 63 patients with an uncontained-type OLT. The median patient age was 34 years (interquartile range [IQR], 28-48 years) in the contained-type group and 36 years (IQR, 27-46 years) in the uncontained-type group. The median follow-up time was 45 months (IQR, 38-63 months) in the contained-type group and 52 months (IQR, 40-66 months) in the uncontained-type group. The median FAOS and SF-12 scores improved significantly after surgery in both contained-type and uncontained-type lesions ( P < .001). The median postoperative FAOS score of patients with contained-type OLTs was higher than that of patients with uncontained-type OLTs (91.7 vs 85.0, respectively; P = .009), but no significant differences were found between the contained-type and uncontained-type groups for postoperative SF-12 and MOCART scores. The multivariate regression models showed that patients with contained-type OLTs had an approximately 10-point better score on the FAOS compared with patients with uncontained-type OLTs ( P = .006). There was a nonsignificant trend for the rate of cystic occurrence in uncontained-type OLTs to be higher than that of contained-type OLTs (55.6% vs 38.7%, respectively; P = .125). CONCLUSION: Patients with contained-type OLTs experienced better clinical outcomes than those with uncontained-type OLTs after AOT for the treatment of OLTs. However, the AOT procedure still provided good clinical and MRI outcomes in both contained-type and uncontained-type OLTs at midterm follow-up.
引用
- Shimozono Y, Donders JCE, Yasui Y, et al. Effect of the Containment Type on Clinical Outcomes in Osteochondral Lesions of the Talus Treated With Autologous Osteochondral Transplantation. Am J Sports Med. 2018. PMID: 29869915. doi:10.1177/0363546518776659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。